Next Article in Journal
Osteogenic Differentiation of Human Gingival Fibroblasts Inhibits Osteoclast Formation
Previous Article in Journal
Sensing of an HIV-1–Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cells
Volume 13
Issue 13
10.3390/cells13131089
cells-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Cells 2022, 11(2), 247.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Bufalo et al. Human Sensory Neuron-like Cells and Glycated Collagen Matrix as a Model for the Screening of Analgesic Compounds. Cells 2022, 11, 247

by
Michelle Cristiane Bufalo
1,2,
Maíra Estanislau Soares de Almeida
2,3,
José Ricardo Jensen
4,
Carlos DeOcesano-Pereira
2,
Flavio Lichtenstein
2,
Gisele Picolo
1,
Ana Marisa Chudzinski-Tavassi
2,5,
Sandra Coccuzzo Sampaio
3,6,
Yara Cury
1,* and
Vanessa Olzon Zambelli
1,2,*
1
Laboratory of Pain and Signaling, Butantan Institute, São Paulo 05503-900, Brazil
2
Center of Excellence in New Target Discovery, Butantan Institute, São Paulo 05503-900, Brazil
3
Laboratory of Pathophysiology, Butantan Institute, São Paulo 05503-900, Brazil
4
Immunogenetics Laboratory, Butantan Institute, São Paulo 05503-900, Brazil
5
Innovation and Development Laboratory, Innovation and Development Center, Butantan Institute, São Paulo 05503-900, Brazil
6
Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-220, Brazil
*
Authors to whom correspondence should be addressed.
Cells 2024, 13(13), 1089; https://doi.org/10.3390/cells13131089
Submission received: 5 June 2024 / Accepted: 10 June 2024 / Published: 24 June 2024
(This article belongs to the Special Issue Mitochondrial Dysfunction in Degenerative Diseases)
Browse Figure
Versions Notes

Error in Figure

In the original publication [1], there was a mistake in Figure 8, Similarity between Control and NC figures, as published. The corrected Figure 8 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Bufalo, M.C.; Almeida, M.E.S.d.; Jensen, J.R.; DeOcesano-Pereira, C.; Lichtenstein, F.; Picolo, G.; Chudzinski-Tavassi, A.M.; Sampaio, S.C.; Cury, Y.; Zambelli, V.O. Human Sensory Neuron-like Cells and Glycated Collagen Matrix as a Model for the Screening of Analgesic Compounds. Cells 2022, 11, 247. [Google Scholar] [CrossRef] [PubMed]
Cells 13 01089 g008
Figure 8. Representative images of immunofluorescence of c-Fos expression. (a) c-Fos expression in sensory neuron-like cells incubated with ECM-NC, ECM-GC, ECM-NC IL-1β or medium culture for 1 h. Magnification: 20×. (b) Quantification of c-Fos nuclear expression (% of control). Data were analyzed by one-way ANOVA with post hoc testing by Dunnett (*** p < 0.0001 different from Control). NC (normal collagen) and GC (glycated collagen). Three independent and similar assays performed in triplicate.
Figure 8. Representative images of immunofluorescence of c-Fos expression. (a) c-Fos expression in sensory neuron-like cells incubated with ECM-NC, ECM-GC, ECM-NC IL-1β or medium culture for 1 h. Magnification: 20×. (b) Quantification of c-Fos nuclear expression (% of control). Data were analyzed by one-way ANOVA with post hoc testing by Dunnett (*** p < 0.0001 different from Control). NC (normal collagen) and GC (glycated collagen). Three independent and similar assays performed in triplicate.
Cells 13 01089 g008
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bufalo, M.C.; Almeida, M.E.S.d.; Jensen, J.R.; DeOcesano-Pereira, C.; Lichtenstein, F.; Picolo, G.; Chudzinski-Tavassi, A.M.; Sampaio, S.C.; Cury, Y.; Zambelli, V.O. Correction: Bufalo et al. Human Sensory Neuron-like Cells and Glycated Collagen Matrix as a Model for the Screening of Analgesic Compounds. Cells 2022, 11, 247. Cells 2024, 13, 1089. https://doi.org/10.3390/cells13131089

AMA Style

Bufalo MC, Almeida MESd, Jensen JR, DeOcesano-Pereira C, Lichtenstein F, Picolo G, Chudzinski-Tavassi AM, Sampaio SC, Cury Y, Zambelli VO. Correction: Bufalo et al. Human Sensory Neuron-like Cells and Glycated Collagen Matrix as a Model for the Screening of Analgesic Compounds. Cells 2022, 11, 247. Cells. 2024; 13(13):1089. https://doi.org/10.3390/cells13131089

Chicago/Turabian Style

Bufalo, Michelle Cristiane, Maíra Estanislau Soares de Almeida, José Ricardo Jensen, Carlos DeOcesano-Pereira, Flavio Lichtenstein, Gisele Picolo, Ana Marisa Chudzinski-Tavassi, Sandra Coccuzzo Sampaio, Yara Cury, and Vanessa Olzon Zambelli. 2024. "Correction: Bufalo et al. Human Sensory Neuron-like Cells and Glycated Collagen Matrix as a Model for the Screening of Analgesic Compounds. Cells 2022, 11, 247" Cells 13, no. 13: 1089. https://doi.org/10.3390/cells13131089

APA Style

Bufalo, M. C., Almeida, M. E. S. d., Jensen, J. R., DeOcesano-Pereira, C., Lichtenstein, F., Picolo, G., Chudzinski-Tavassi, A. M., Sampaio, S. C., Cury, Y., & Zambelli, V. O. (2024). Correction: Bufalo et al. Human Sensory Neuron-like Cells and Glycated Collagen Matrix as a Model for the Screening of Analgesic Compounds. Cells 2022, 11, 247. Cells, 13(13), 1089. https://doi.org/10.3390/cells13131089

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop